English | Español
Patient Daily | Mar 11, 2026

Roche invests $480 million to expand clinical trial capacity in South Korea
Patient Daily | Mar 11, 2026

FDA partially pauses PepGen's phase 2 trial for myotonic dystrophy
Patient Daily | Mar 11, 2026

FDA official seeks hire amid controversy over antidepressant warnings
Patient Daily | Mar 11, 2026

Alnylam partners with Tenaya Therapeutics on genetic heart disease research
Patient Daily | Mar 11, 2026

Analysts say psychedelics unlikely to dominate depression treatment market
Patient Daily | Mar 11, 2026

UniQure weighs next steps after FDA requests new phase 3 trial for Huntington's gene therapy
Patient Daily | Mar 11, 2026

Targeted mRNA restores fertility in genetically infertile male mice
Patient Daily | Mar 11, 2026

Study links impaired tanycyte function to tau buildup in Alzheimer’s disease

Trending
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Revolution and Ascendis identified as top buyout targets amid speculation of industry mega-merger
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Sarepta to seek full FDA approval for Duchenne therapies after failed confirmatory trial
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Lilly reports late-stage diabetes data for triple-G agonist retatrutide
+ Regulatory
Patient Daily | Mar 30, 2026

Freedom Foundation CEO Meeks on 340B: 'The program has morphed into a veritable ATM for hospitals'